OFFICE OF THE GENERAL COUNSEL
Nevada State Board of Medical Examiners
9600 Gateway Drive
Reno, Nevada 89521
(775) 688-2559

"1

BEFORE THE BOARD OF MEDICAL EXAMINERS

OF THE STATE OF NEVADA
In the Matter of Charges and Complaint Case No. 23-11289-2
Against: FilcD
STEPHEN PAUL DUBIN M.D., OCT 31 2023
Respondent. NEVADA STATE BOARD QF
MED! ‘AMINERS
By:
COMPLAINT

The Investigative Committee! (IC) of the Nevada State Board of Medical Examiners
(Board), by and through William P. Shogren, Deputy General Counsel and attorney for the IC,
having a reasonable basis to believe that Stephen Paul Dubin, M.D., (Respondent) violated the
provisions of Nevada Revised Statutes (NRS) Chapter 630 and Nevada Administrative Code (NAC)
Chapter 630 (collectively, the Medical Practice Act), hereby issues its Complaint, stating the IC’s
charges and allegations as follows:

1, Respondent was at all times relative to this Complaint a medical doctor holding an
active license to practice medicine in the State of Nevada (License No. 13772). Respondent was
originally licensed by the Board on December 3, 2010.

2. Respondent, at all times relevant to this Complaint, held an active Certificate of
Registration with the Nevada State Board of Pharmacy (Pharmacy Board), No. CS19164.

3. On August 13, 2021, the Pharmacy Board filed a Notice of Intended Action and
Accusation (Accusation) against Respondent, alleging that between December 18, 2018, and
December 20, 2018, while acting as medical director of Jireh Healthcare, Respondent violated
various statutes and regulations within the Pharmacy Board’s jurisdiction.

‘11

' The Investigative Committee of the Nevada State Board of Medical Examiners, at the time this formal
Complaint was authorized for filing, was composed of Board members Bret W. Frey, M.D., Col. Eric D. Wade,
USAF (Ret.) and Carl N. Williams, Jr., M.D., FACS.


Reno, Nevada 89521
(775) 688-2559

Nevada State Board of Medical Examiners
9600 Gateway Drive

OFFICE OF THE GENERAL COUNSEL


4. In pertinent part, the Pharmacy Board Accusation alleged that Respondent pre-
signed, post-signed, or allowed staff to call in controlled substance prescriptions for patients
without Respondent’s dated and handwritten signature, while Respondent was engaged in
overseas travel.

5. On September 7, 2022, the Pharmacy Board issued a Findings of Facts,
Conclusions of Law, and Order (Order), hereto attached as Exhibit 1. The Pharmacy Board found
that Respondent, as medical director with supervisory duties over clinical staff, pre-signed, post-
signed, or allowed staff to call in controlled substance prescriptions for patients without
Respondent’s dated and handwritten signature, while Respondent was engaged in overseas travel.
The Pharmacy Board further found that Respondent was a party to a fraudulent or deceitful
practice or transaction and engaged in unprofessional conduct and conduct contrary to the public
interest. The Pharmacy Board found that Respondent violated NAC 639.945(1)(h)-(i),
NRS 453.236(1), NRS 453.331, and was subject to discipline pursuant to NRS 453.236,
NRS 453.241, and/or NRS 639.210. The Pharmacy Board also found that Respondent violated,
attempted to violate, assisted or abetted in the violation of or conspirted to violate various federal
laws, and was subject to discipline pursuant to NRS 639.210(11).

6. The Pharmacy Board, in its Order, ordered that Respondent be disciplined as
follows: (1) that Respondent’s controlled substance registration be placed on probation for two (2)
years; (2) that Respondent pay fines and costs; (3) that Respondent complete four (4) additional
continuing education classes regarding proper prescribing of controlled substances; (4) that
Respondent complete one (1) hour of PMP training with Pharmacy Board staff; (5) that
Respondent complete one (1) hour of controlled substance prescribing training; and (6) that the
Order serve as a public reprimand.

COUNTI
NRS 630.306(1)(b)(3) — Violation of Statutes and Regulations of the Nevada State
Board of Pharmacy
7. All of the allegations contained in the above paragraphs are hereby incorporated by

reference as though fully set forth herein.


9600 Gateway Drive
Reno, Nevada 89521
(775) 688-2559

OFFICE OF THE GENERAL COUNSEL
Nevada State Board of Medical Examiners


8. Respondent is a practitioner as defined by NRS 639.0125(1), as a physician who
holds a license to practice medicine in the State of Nevada.

9. NRS 630.306(1)(b)(3) provides that engaging in conduct that violates a provision
of Chapter 639 of NRS, or a regulation adopted by the Pharmacy Board pursuant thereto, that is
applicable to a licensee who is a practitioner, as defined in NRS 639.0125, is grounds for initiating
discipline against a licensee.

10. NAC 639.945(1)(h)-(i) are regulations adopted by the Pharmacy Board pursuant to
Chapter 639 of NRS. NRS 639.210(11) is a provision of Chapter 639 of NRS.

ll. Respondent violated NRS 630.306(1)(b)(3) when the Pharmacy Board issued its
Order and found that Respondent violated NAC 639.945(1)(h)-(i) and/or NRS 639.210(11).
See Exhibit 1.

12. By reason of the foregoing, Respondent is subject to discipline by the Board as
provided in NRS 630.352.

WHEREFORE, the Investigative Committee prays:

1. That the Board give Respondent notice of the charges herein against her and give
him notice that she may file an answer to the Complaint herein as set forth in
NRS 630.339(2) within twenty (20) days of service of the Complaint;

2. That the Board set a time and place for a formal hearing after holding an Early
Case Conference pursuant to NRS 630.339(3);

3. That the Board determine what sanctions to impose if it determines there has been
a violation or violations of the Medical Practice Act committed by Respondent;

4. That the Board award fees and costs for the investigation and prosecution of this
case as outlined in NRS 622.400;

5. That the Board make, issue and serve on Respondent its findings of fact,
conclusions of law and order, in writing, that includes the sanctions imposed; and



OFFICE OF THE GENERAL COUNSEL
Nevada State Board of Medical Examiners
9600 Gateway Drive
Reno, Nevada 89521
(775) 688-2559


15,

6.

premises.

That the Board take such other and further action as may be just and proper in these

DATED this 31st day of October, 2023.

INVESTIGATIVE COMMITTEE OF THE
NEVADA STATE BOARD OF MEDICAL EXAMINERS

WILLIAM P. SHOGREN

Deputy General Counsel

9600 Gateway Drive

Reno, NV 89521

Tel: (775) 688-2559

Email: dcontine@medboard.nv.gov

Attorney for the Investigative Committee

40f5

9600 Gateway Drive
Reno, Nevada 89521
(775) 688-2559

OFFICE OF THE GENERAL COUNSEL
Nevada State Board of Medical Examiners

ul

VERIFICATION
STATE OF NEVADA )

COUNTY OF CLARK )

Bret W. Frey, M.D., having been duly sworn, hereby deposes and states under penalty of
perjury that he is the Chairman of the Investigative Committee of the Nevada State Board of
Medical Examiners that authorized the Complaint against the Respondent herein; that he has read
the foregoing Complaint; and that based upon information discovered in the course of the
investigation into a complaint against Respondent, he believes that the allegations and charges in
the foregoing Complaint against Respondent are true, accurate and correct.

DATED this 3l day of October, 2023.

INVESTIGATIVE COMMITTEE OF THE
NEVADA STATE BOARD OF MEDICAL EXAMINERS

Chairman ®f the Investigative Committee


CERTIFICATE OF SERVICE
I hereby certify that I am employed by the Nevada State Board of Medical Examiners and

that on the Ist day of November, 2023, I served a file-stamped copy of the foregoing


COMPLAINT via U.S Certified Mail to:

DATED this \

STEPHEN PAUL DUBIN, M.D.
2359 Cliffwood Dr.
Henderson, NV 89074

Tracking No. 9171 9690 0935 0241 5577 35

day of November, 2023.

MERCEDE NTES
Legal Assistan
Nevada State Board of Medical Examiners

EXHIBIT 1

EXHIBIT 1
ILED

AUG 1 3 2021
NEVADA STATE BOARD

BEFORE THE NEVADA STATE BOARD OF PHARMACY

NEVADA STATE BOARD OF PHARMACY, CASENO.  20-020-CS-S
Petitioner,
Vv
NOTICE OF INTENDED ACTION
STEPHEN DUBIN, MD, AND ACCUSATION
Certificate of Registration No. CS19164,
Respondent.

J. David Wuest, in his official capacity as Executive Secretary of the Nevada State Board
of Pharmacy, makes the following that will serve as both a notice of intended action under NRS
233B.127(3) and as an accusation under NRS 622A,300(1) and NRS 639.241.

JURISDICTION

1. The Nevada State Board of Pharmacy (“Board”) has jurisdiction over this matter
because at the time of the events alleged herein, Respondent Stephen P. Dubin, MD (“Dubin”),
held a controlled substance registration, Certificate of Registration No. CS19164, issued by the
Board.

FACTUAL ALLEGATIONS

2. Respondent Dubin is/was the medical director of a home hospice company, Jireh
Healthcare (“Jireh”), located at 2320 Paseo Del Prado, Suite B101, Lus Vegas, Nevada 89102.

3. Jirch employs registered nurses and/or physician assistants, who are agents or
staff members for Dubin, to travel to patients’ homes to provide in-home hospice services.

4, Respondent Dubin did not travel to patients’ homes to examine patients in person
nor did Dubin directly consult with patients by other electronic or remote device.

5. The United States Department of Justice filed a referral for civil prosecution
against Respondent Dubin for prescribing controlled substances prescriptions while out of the

country.
6. Dubin was outside of the United States from December 17-24, 2018.

7. On December 18, 2018, Dubin’s agent or staff member “Honey” called in a
controlled substance schedule IV prescription for patient A.D. for Alprazolam | mg tablet,
quantity 15.

8. On December 19, 2018, Dubin's agent or staff member “Speedy” called in a
controlled substance schedule II prescription for patient M.G. for oxycodone 10-325 mg tablets,
quantity 60.

9. On December 19, 2018, Dubin’s agent or staff member “Speedy” called in a
controlled substance schedule IV prescription for patient M.H. for Lorazepam 0.5 mg tablets,
quantity 45,

10. Patient D.B. started care with Jireh on December 20, 2018 and was discharged on
December 22, 2018 because he passed away, all during the time when Dubin was out of the
country.

Il. On December 20, 2018, Dubin’s agent or staff member “Honey” called in a
controlled substance schedule II prescription for patient D.B. for Morphine Sulfate 20 mg/ml,
quantity 30.

12. On December 20, 2018, Dubin’s agent or staff member “Honey” called in a
controlled substance schedule IV prescription for patient D.B. for Lorazepam 2mg/ml, quantity
30.

13. All of the foregoing controlled substance prescriptions were telephoned by
Dubin's agent(s) or staff member(s) to Trinity Pharmacy during a time when Dubin was out of
the country.

APPLICABLE LAW
14. No person other than a practitioner holding a license to practice his or her

profession in this State may prescribe or write a prescription. NRS 639.235(1).

15. A prescription for a controlled substance may be issued only for a legitimate
medical purpose and in the usual course of his or her professional practice by an individual
practitioner who holds a DEA registration and is authorized to prescribe controlled substances by
the jurisdiction in which he is licensed to practice his profession. 21 USC § 822(a)(2); 21 USC §
823(f); 21 CFR § 1306.03(a)(1); NRS 453.331; NRS 453.431; NRS 453.381(1).

16. It is unlawful for a practitioner to prescribe a controlled substance except as
authorized by law. NRS 453.226(1); NRS 453.256; NRS 453,321(1)(a); NRS 453.431; NRS
639.100(1); NRS 639.235; NRS 639.23505; NRS 639.2353; NRS 639.2355; NRS
639.239145(2)(a); NAC 453.410; NAC 453.420; NAC 453.440; NAC 453.450; NAC 639.742;
NAC 639.745.

17, It is a felony offense to falsify a prescription for a controlled substance or
otherwise purchase or possess a controlled substance except as authorized by law. 21 USC §
841(a); 21 USC § 842(a); NRS 453.331(1)(c), (d), (f), (h) and (i).

18. Conspiring to violate the Controlled Substances Act is a felony offense. 21
USC § 846; NRS 453.401(1)(a).

19. Performing or in any way being a party to any fraudulent or deceitful practice or
transaction constitutes unprofessional conduct or conduct contrary to the public interest pursuant
to NAC 639.945(1)(h), and is grounds for suspension or revocation of any license or registration
issued by the Board. NRS 639.210(4).

20. Performing any duties as the holder of a controlled substance registration in an
incompetent, unskillful or negligent manner constitutes unprofessional conduct or conduct
contrary to the public interest pursuant to NAC 639.945(1)(i), and is grounds for suspension or
revocation of any license or registration issued by the Board. NRS 639.210(4).

21. Prescribing a drug as a practitioner to a patient with whom the practitioner does

not have a bona fide therapeutic relationship pursuant to NRS 639.235(2)(a), NRS

639.239145(2)(a) constitutes unprofessional conduct or conduct contrary to the public interest
pursuant to NAC 639.945(1)(n) and (0), and is grounds for suspension or revocation of any
license or registration issued by the Board. NRS 639.210(4).

22. Aiding or abetting a person not licensed to practice pharmacy in the State of
Nevada constitutes unprofessional conduct or conduct contrary to the public interest pursuant to
NAC 639,945(1)(j), and is grounds for suspension or revocation of any license or registration
issued by the Board. NRS 639.210(4).

23. Violating any provision of the Federal Food, Drug and Cosmetic Act or any other
federal law or regulation relating to prescription drugs is grounds for suspension or revocation of
any license or registration issued by the Board. NRS 639.210(11).

24. Violating, attempting to violate, assisting or abetting in the violation of or
conspiring to violate any law or regulation relating to drugs is grounds for suspension or
revocation of any license or registration issued by the Board. NRS 639.210(12).

25. The Board may suspend or revoke a registration issued pursuant to NRS 453.231
to prescribe or otherwise dispense a controlled substance upon a finding that the registrant has
committed an act that would render registration inconsistent with the public interest. NRS

453.236(1)(d) and NRS 453.241(1).

\T CAUSE OF ACTION
Unprofessional Conduct — Party to a Fraudulent/Deceitful Practice/Transaction
26. —_ By pre-signing, post-signing, or allowing staff to call in controlled substance
schedule II prescriptions for patients without Dubin’s dated and handwritten signature while
Dubin was engaged in overseas travel, Dubin was a party to a fraudulent or deceitful practice or
transaction and engaged in unprofessional conduct and conduct contrary to the public interest in
violation of NAC 639.945(1)(h)(i), NRS 453.236(1), NRS 453.331, and is subject to discipline

pursuant to NRS 453.236, NRS 453.241, and/or NRS 639.210.
SECOND CAUSE OF ACTION
Unprofessional Conduct — Incompetent, Unskillful or Negligent Performance of Duties

27. _ By pre-signing, post-signing, or allowing staff to call in controlled substance
schedule II prescriptions for patients without Dubin’s dated and handwritten signature while
Dubin was engaged in overseas travel, and when no bona fide therapeutic relationships with
patients were established, Dubin performed his duty as a holder of a Nevada Controlled
Substance Registration in an incompetent, unskillful or negligent manner and engaged in
unprofessional conduct in violation of NRS 453.331, and NAC 639.945(1)(i), and (0), and is
subject to discipline pursuant to NRS 453.236(1) and NRS 639.210.

THIRD CAUSE OF ACTION
Violations of the Federal and State Controlled Substances Act

28. By pre-signing, post-signing, or permitting his staff to telephone controlled
substances schedule II prescriptions without Dubin’s dated and handwritten signature, Dubin
violated, attempted to violate, assisted or abetted in the violation of or conspired to violate 21
USC § 822(a)(2), 21 USC § 823(f), 21 USC § 841(a), 21 USC § 842(a), 21 USC § 846 and 21
CFR 8§ 1306.03-1306.05, NRS 453.331, and is subject to discipline pursuant to NRS
453.236(1) and NRS 639,210(11),

FOURTH CAUSE OF ACTION
Commission of Acts that Render Registration Inconsistent with the Public Interest

29. Asset forth herein, Dubin has committed acts that render his registration to
prescribe controlled substances inconsistent with the public interest pursuant to NRS 453.231,
and is subject to discipline pursuant to NRS 453.236(1)(d) and NRS 453.241(1).

WHEREFORE it is requested that the Nevada State Board of Pharmacy take appropriate
disciplinary action with respect to the certificate of registration of this Respondent.

DATED this 13!" day of August, 2021.

idWuest, R.Ph., Executive Secretary
Vada State Board of Pharmacy

